Former OpenAI CEO Sam Altman Joins Microsoft for Advanced AI Research

Date:

Former OpenAI CEO Sam Altman has joined Microsoft for advanced AI research, according to Microsoft CEO Satya Nadella. Altman, along with Chairman Greg Brockman, will lead a new team focused on advanced AI research. This announcement comes just days after Altman and Brockman departed from their positions at OpenAI. Microsoft had previously invested over $10 billion in OpenAI and formed a partnership with the company earlier this year. Altman’s departure from OpenAI was reportedly due to a conflict with the company’s board. Despite rumors of a possible return to OpenAI, Altman has chosen to join Microsoft. Microsoft’s stock fell by 1.98% following the news of Altman’s firing, but Nadella reiterated the company’s confidence in its current product roadmap. The arrival of Altman and Brockman to Microsoft’s advanced AI research team is seen as a significant development in the field of artificial intelligence.

See also  Microsoft's Copilot AI Assistant Set to Introduce Paid Subscription with New 'Copilot Pro' Tier, Implying an End to Free Access

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.